Search research articles
Contact Us
Filters
Showing results (161-170 of 169) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 169 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2005
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI
Günther Gruber, Marco Bonetti, M Laura Nasi, et al.
The International Journal of Artificial Organs
|
July 29, 2006
Minimized weight gain between hemodialysis contributes to a reduced risk of death
B G Stegmayr, M Brannstrom, S Bucht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2007
The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer
Per Karlsson, Bernard F Cole, Karen N Price, et al.
Scandinavian Journal of Urology and Nephrology
|
December 29, 2007
Low-dose atorvastatin in severe chronic kidney disease patients: a randomized, controlled endpoint study
B G Stegmayr, M Brännström, S Bucht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2005
Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience
Marco Colleoni, David Zahrieh, Richard D Gelber, et al.
British Journal of Cancer
|
June 28, 2002
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
M Colleoni, H J Litman, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
G Berclaz, S Li, K N Price, et al.
Lancet (London, England)
|
February 20, 2007
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R C Coombes, L S Kilburn, C F Snowdon, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 4, 2016
Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)
A S Allal, C Ares, P Dulguerov, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 169) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 169 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2005
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI
Günther Gruber, Marco Bonetti, M Laura Nasi, et al.
The International Journal of Artificial Organs
|
July 29, 2006
Minimized weight gain between hemodialysis contributes to a reduced risk of death
B G Stegmayr, M Brannstrom, S Bucht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 11, 2007
The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer
Per Karlsson, Bernard F Cole, Karen N Price, et al.
Scandinavian Journal of Urology and Nephrology
|
December 29, 2007
Low-dose atorvastatin in severe chronic kidney disease patients: a randomized, controlled endpoint study
B G Stegmayr, M Brännström, S Bucht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2005
Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience
Marco Colleoni, David Zahrieh, Richard D Gelber, et al.
British Journal of Cancer
|
June 28, 2002
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
M Colleoni, H J Litman, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
G Berclaz, S Li, K N Price, et al.
Lancet (London, England)
|
February 20, 2007
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R C Coombes, L S Kilburn, C F Snowdon, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 4, 2016
Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO)
A S Allal, C Ares, P Dulguerov, et al.
Page
of 17